![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 11294 |
FusionGeneSummary for EIF3M_EIF3M |
![]() |
Fusion gene information | Fusion gene name: EIF3M_EIF3M | Fusion gene ID: 11294 | Hgene | Tgene | Gene symbol | EIF3M | EIF3M | Gene ID | 10480 | 10480 |
Gene name | eukaryotic translation initiation factor 3 subunit M | eukaryotic translation initiation factor 3 subunit M | |
Synonyms | B5|GA17|PCID1|TANGO7|hfl-B5 | B5|GA17|PCID1|TANGO7|hfl-B5 | |
Cytomap | 11p13 | 11p13 | |
Type of gene | protein-coding | protein-coding | |
Description | eukaryotic translation initiation factor 3 subunit MB5 receptorPCI domain containing 1 (herpesvirus entry mediator)PCI domain-containing protein 1dendritic cell proteinfetal lung protein B5transport and golgi organization 7 homolog | eukaryotic translation initiation factor 3 subunit MB5 receptorPCI domain containing 1 (herpesvirus entry mediator)PCI domain-containing protein 1dendritic cell proteinfetal lung protein B5transport and golgi organization 7 homolog | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q7L2H7 | Q7L2H7 | |
Ensembl transtripts involved in fusion gene | ENST00000531120, ENST00000524896, ENST00000532054, | ENST00000531120, ENST00000524896, ENST00000532054, | |
Fusion gene scores | * DoF score | 6 X 7 X 3=126 | 7 X 5 X 4=140 |
# samples | 7 | 8 | |
** MAII score | log2(7/126*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/140*10)=-0.807354922057604 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: EIF3M [Title/Abstract] AND EIF3M [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BQ428530 | EIF3M | chr11 | 32611166 | - | EIF3M | chr11 | 32616460 | + | ||
ChiTaRS3.1 | CA312302 | EIF3M | chr11 | 32623319 | - | EIF3M | chr11 | 32617512 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000531120 | ENST00000531120 | EIF3M | chr11 | 32611166 | - | EIF3M | chr11 | 32616460 | + |
In-frame | ENST00000531120 | ENST00000524896 | EIF3M | chr11 | 32611166 | - | EIF3M | chr11 | 32616460 | + |
5CDS-intron | ENST00000531120 | ENST00000532054 | EIF3M | chr11 | 32611166 | - | EIF3M | chr11 | 32616460 | + |
In-frame | ENST00000524896 | ENST00000531120 | EIF3M | chr11 | 32611166 | - | EIF3M | chr11 | 32616460 | + |
In-frame | ENST00000524896 | ENST00000524896 | EIF3M | chr11 | 32611166 | - | EIF3M | chr11 | 32616460 | + |
5CDS-intron | ENST00000524896 | ENST00000532054 | EIF3M | chr11 | 32611166 | - | EIF3M | chr11 | 32616460 | + |
intron-3CDS | ENST00000532054 | ENST00000531120 | EIF3M | chr11 | 32611166 | - | EIF3M | chr11 | 32616460 | + |
intron-3CDS | ENST00000532054 | ENST00000524896 | EIF3M | chr11 | 32611166 | - | EIF3M | chr11 | 32616460 | + |
intron-intron | ENST00000532054 | ENST00000532054 | EIF3M | chr11 | 32611166 | - | EIF3M | chr11 | 32616460 | + |
Frame-shift | ENST00000531120 | ENST00000531120 | EIF3M | chr11 | 32623319 | - | EIF3M | chr11 | 32617512 | + |
Frame-shift | ENST00000531120 | ENST00000524896 | EIF3M | chr11 | 32623319 | - | EIF3M | chr11 | 32617512 | + |
5CDS-intron | ENST00000531120 | ENST00000532054 | EIF3M | chr11 | 32623319 | - | EIF3M | chr11 | 32617512 | + |
Frame-shift | ENST00000524896 | ENST00000531120 | EIF3M | chr11 | 32623319 | - | EIF3M | chr11 | 32617512 | + |
Frame-shift | ENST00000524896 | ENST00000524896 | EIF3M | chr11 | 32623319 | - | EIF3M | chr11 | 32617512 | + |
5CDS-intron | ENST00000524896 | ENST00000532054 | EIF3M | chr11 | 32623319 | - | EIF3M | chr11 | 32617512 | + |
intron-3CDS | ENST00000532054 | ENST00000531120 | EIF3M | chr11 | 32623319 | - | EIF3M | chr11 | 32617512 | + |
intron-3CDS | ENST00000532054 | ENST00000524896 | EIF3M | chr11 | 32623319 | - | EIF3M | chr11 | 32617512 | + |
intron-intron | ENST00000532054 | ENST00000532054 | EIF3M | chr11 | 32623319 | - | EIF3M | chr11 | 32617512 | + |
Top |
FusionProtFeatures for EIF3M_EIF3M |
![]() |
Hgene | Tgene |
EIF3M | EIF3M |
Component of the eukaryotic translation initiationfactor 3 (eIF-3) complex, which is required for several steps inthe initiation of protein synthesis (PubMed:17403899,PubMed:25849773, PubMed:27462815). The eIF-3 complex associateswith the 40S ribosome and facilitates the recruitment of eIF-1,eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNArecruitment to the 43S PIC and scanning of the mRNA for AUGrecognition. The eIF-3 complex is also required for disassemblyand recycling of post-termination ribosomal complexes andsubsequently prevents premature joining of the 40S and 60Sribosomal subunits prior to initiation (PubMed:17403899). The eIF-3 complex specifically targets and initiates translation of asubset of mRNAs involved in cell proliferation, including cellcycling, differentiation and apoptosis, and uses different modesof RNA stem-loop binding to exert either translational activationor repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03012,ECO:0000269|PubMed:17403899, ECO:0000269|PubMed:25849773,ECO:0000269|PubMed:27462815}. (Microbial infection) May favor virus entry in case ofinfection with herpes simplex virus 1 (HSV1) or herpes simplexvirus 2 (HSV2). {ECO:0000269|PubMed:15919898}. | Component of the eukaryotic translation initiationfactor 3 (eIF-3) complex, which is required for several steps inthe initiation of protein synthesis (PubMed:17403899,PubMed:25849773, PubMed:27462815). The eIF-3 complex associateswith the 40S ribosome and facilitates the recruitment of eIF-1,eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNArecruitment to the 43S PIC and scanning of the mRNA for AUGrecognition. The eIF-3 complex is also required for disassemblyand recycling of post-termination ribosomal complexes andsubsequently prevents premature joining of the 40S and 60Sribosomal subunits prior to initiation (PubMed:17403899). The eIF-3 complex specifically targets and initiates translation of asubset of mRNAs involved in cell proliferation, including cellcycling, differentiation and apoptosis, and uses different modesof RNA stem-loop binding to exert either translational activationor repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03012,ECO:0000269|PubMed:17403899, ECO:0000269|PubMed:25849773,ECO:0000269|PubMed:27462815}. (Microbial infection) May favor virus entry in case ofinfection with herpes simplex virus 1 (HSV1) or herpes simplexvirus 2 (HSV2). {ECO:0000269|PubMed:15919898}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >EIF3M | chr11:32611166 | chr11:32616460 | ENST00000531120 | + | 1 | 11 | 180_339 | -21 | 375 | Domain | PCI |
Tgene | EIF3M | chr11:32611166 | chr11:32616460 | ENST00000531120 | + | 5 | 11 | 180_339 | 205 | 375 | Domain | PCI |
Top |
FusionGeneSequence for EIF3M_EIF3M |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for EIF3M_EIF3M |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
EIF3M | EIF1B, EIF4A2, EIF3A, EIF3F, EIF3H, TADA2A, EIF3B, APP, EIF3C, EIF3E, EIF3D, EIF3I, EIF3K, EIF3L, EIF3G, MMS19, NPM1, EXOSC10, SRPK1, FAM96B, HUWE1, EGFR, EIF3CL, USP34, HSPB1, AHCYL1, COPS4, RPN1, EIF3J, NTRK1, MED4, HERC2, NF2, PTP4A1, PSMD12, EIF4A1, GPBP1L1, UBE2N, CYLD, DLD, TRIM25, G3BP1, BRCA1 | EIF3M | EIF1B, EIF4A2, EIF3A, EIF3F, EIF3H, TADA2A, EIF3B, APP, EIF3C, EIF3E, EIF3D, EIF3I, EIF3K, EIF3L, EIF3G, MMS19, NPM1, EXOSC10, SRPK1, FAM96B, HUWE1, EGFR, EIF3CL, USP34, HSPB1, AHCYL1, COPS4, RPN1, EIF3J, NTRK1, MED4, HERC2, NF2, PTP4A1, PSMD12, EIF4A1, GPBP1L1, UBE2N, CYLD, DLD, TRIM25, G3BP1, BRCA1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Tgene | EIF3M | chr11:32611166 | chr11:32616460 | ENST00000531120 | + | 5 | 11 | 344_374 | 205 | 375 | HSV-1 and HSV-2 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | EIF3M | chr11:32611166 | chr11:32616460 | ENST00000531120 | + | 1 | 11 | 344_374 | -21 | 375 | HSV-1 and HSV-2 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for EIF3M_EIF3M |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for EIF3M_EIF3M |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |